Gastrointestinal stromal tumors (GISTs) are rare, comprising less than 1% of all such tumors. Yet, they are the most common type of sarcoma affecting the GI tract. With an annual incidence of approximately 10 to 15 cases per million people, these tumors, if left undetected and untreated, can pose significant health risks. It is imperative to understand the causes of GISTs to facilitate early detection and intervention.

In this blog, we delve into the factors contributing to the development of GISTs, including genetic mutations and environmental influences.

What Are Gastrointestinal Stromal Tumors?

Gastrointestinal stromal tumors (GISTs) are soft tissue sarcomas originating in the gastrointestinal (GI) tract, most commonly in the stomach or small intestine. These tumors are typically slow-growing and may not cause symptoms in the early stages. However, as they grow larger or spread to other parts of the body, they can cause abdominal pain, bleeding, and other complications.

Dr. Deep is a renowned expert in Gastrointestinal Stromal Tumors (GISTs) in India, and he is known for his pioneering work in understanding and treating this condition. His extensive experience and compassion have helped numerous patients achieve positive outcomes. His expertise encompasses surgical and non-surgical management strategies, ensuring comprehensive care tailored to each patient’s needs.

What is the Cause of Gastrointestinal Stromal Tumors?

This condition usually happens when the KIT gene mutates (changes) and causes cells in your digestive tract to multiply uncontrollably. This mutation occurs during your lifetime and isn’t something that you inherit.

The KIT gene tells cells to make a protein (KIT CD117) that makes cells in your digestive tract multiply. In GIST, the abnormal cells multiply and develop into tumors.

You can also develop GIST if you inherit certain tumor disorders, including:

• Familial GIST syndrome: Familial GIST syndrome is a rare genetic condition that inherits abnormal KIT or PDGFRA genes, predisposing individuals to developing GISTs. Compared to sporadic cases, those with familial GIST syndrome are more likely to develop GISTs at a younger age. Furthermore, individuals with this syndrome often develop multiple tumors, impacting various parts of the digestive tract.
• Neurofibromatosis type 1: Neurofibromatosis type 1 (NF1) is a genetic disorder that causes tumors to grow along nerves in the skin, brain, and other body parts. While GISTs are not as common in NF1 as in different tumor types, individuals with NF1 have an elevated risk of developing GISTs compared to the general population.
• Carney-Stratakis syndrome: Carney-Stratakis syndrome is a scarce inherited condition characterized by the development of GISTs and paragangliomas (tumors that develop from nerve tissue) in the head, neck, and abdomen. This syndrome is caused by mutations in the SDH complex genes, which affect cell metabolism. Due to these genetic mutations, individuals with Carney-Stratakis syndrome have an increased risk of developing GISTs.

Dr Deep mentions, “Gastrointestinal Stromal Tumors (GISTs) are rare but can be serious. If you have symptoms like abdominal pain or blood in your stool, it’s important to see a doctor for an evaluation. Treatment options include surgery, targeted therapy, and sometimes chemotherapy. With early detection and the right treatment plan, many patients can manage GISTs effectively and lead healthy lives.”

“I was diagnosed with Gastrointestinal Stromal Tumor (GIST) last year. It was a frightening experience, but thanks to the timely intervention and care at the hospital, I am now on the path to recovery. The doctors explained everything clearly and guided me through the treatment process. I am grateful for their expertise and the support of my family during this challenging time.” – Ramesh Gupta.

“I was devastated when I found out about my GIST diagnosis. However, the medical team in India provided me with exceptional care and support. They tailored a treatment plan specifically for me and ensured I understood every step of the process. I am grateful for their expertise and dedication today, as I live a healthy post-treatment.” – Priya Patel.

What is the Cost of Treating Gastrointestinal Stromal Tumors in India?

The cost of treating Gastrointestinal Stromal Tumor (GIST) in India can vary depending on the hospital, the tumor stage, the specific treatment plan, and other factors. Generally, the cost of treatment for GIST in India can range from INR 4,00,000 to INR 10,00,000 or more for surgery, chemotherapy, targeted therapy, and follow-up care.

This would cost approximately $5,300 to $13,300 or more. However, these are rough estimates, and the cost can vary widely. It’s essential to consult with healthcare providers and hospitals in India to get specific cost estimates based on individual circumstances.

Conclusion

While the exact cause of GISTs remains unknown, genetic mutations are believed to play a significant role in their development. Understanding the genetic and environmental factors contributing to the risk of developing GISTs is crucial for early detection and treatment. Raising awareness of this rare but potentially life-threatening condition can help improve outcomes for patients with GISTs worldwide.

FAQs

1. What are the symptoms of Gastrointestinal Stromal Tumors (GISTs)?

Symptoms may include abdominal pain, blood in stool, fatigue, and unexplained weight loss.

2. How are GISTs diagnosed?

Diagnosis typically involves imaging tests (CT scan, MRI), biopsy, and molecular testing to detect genetic mutations.

3. What are the treatment options for GISTs?

Treatment may include surgery, targeted therapy (imatinib, sunitinib), and, in some cases, chemotherapy or radiation therapy.

4. Can GISTs be prevented?

Since the exact cause is unknown, no specific preventive measures are available. However, regular check-ups and early detection can help manage the condition effectively.

5. What is the prognosis for GIST patients?

The prognosis varies depending on the tumor’s size, location, stage, and response to treatment. Early detection and treatment can improve outcomes.

Explore more blogs: Is Gastrointestinal Stromal Tumor Surgery Right for You?